Pathophysiology and Management of Variceal Bleeding.

作者: Sunguk Jang , Saleh A. Alqahtani

DOI: 10.1007/S40265-021-01493-2

关键词: Portal hypertensionRisk of mortalityPortal venous pressureEsophageal varicesHemostasisCause of deathMedicineIntensive care medicineCirrhosisVarices

摘要: Cirrhosis is the fifth leading cause of death in adults. Advanced cirrhosis can significant portal hypertension (PH), which responsible for many complications observed patients with cirrhosis, such as varices. If pressure exceeds a certain threshold, patient at risk developing life-threatening bleeding from Variceal has high incidence among liver and carries mortality morbidity. The management variceal complex, often requiring multidisciplinary approach involving pharmacological, endoscopic, radiologic interventions. In terms management, three stages be considered: primary prophylaxis, active bleeding, secondary prophylaxis. main goal prophylaxis to prevent bleeding. However, medical emergency that requires swift intervention stop achieve durable hemostasis. We describe pathophysiology PH contextualize formation gastric esophageal also discuss currently available treatments compare how they fare each stage clinical special focus on drugs or assist achieving

参考文章(212)
Lan Li, Chaohui Yu, Youming Li, Endoscopic band ligation versus pharmacological therapy for variceal bleeding in cirrhosis: A meta-analysis Canadian Journal of Gastroenterology & Hepatology. ,vol. 25, pp. 147- 155 ,(2011) , 10.1155/2011/346705
Velimir A. Luketic, Arun J. Sanyal, Esophageal varices. I. Clinical presentation, medical therapy, and endoscopic therapy. Gastroenterology Clinics of North America. ,vol. 29, pp. 337- 385 ,(2000) , 10.1016/S0889-8553(05)70119-9
Angels Escorsell, Jaime Bosch, Pathophysiology of variceal bleeding Springer, Dordrecht. pp. 155- 166 ,(2004) , 10.1007/978-94-007-1042-9_18
P Cales, J. P Pascal, Histoire naturelle des varices oesophagiennes au cours de la cirrhose (de la naissance à la rupture) Gastroenterologie Clinique Et Biologique. ,vol. 12, pp. 245- 254 ,(1988)
B L Erstad, M D Katz, Octreotide, a new somatostatin analogue Clinical pharmacy. ,vol. 8, pp. 255- 273 ,(1989)
Wen Jie Dai, Advances in gene therapy of liver cirrhosis: a review World Journal of Gastroenterology. ,vol. 7, pp. 1- 8 ,(2001) , 10.3748/WJG.V7.I1.1
Sylvie Naveau, Gabriel Perlemuter, Axel Balian, Epidemiology and natural history of cirrhosis La Revue du praticien. ,vol. 55, pp. 1527- 1532 ,(2005)
Roberto de Franchis, Expanding consensus in portal hypertension Journal of Hepatology. ,vol. 63, pp. 743- 752 ,(2015) , 10.1016/J.JHEP.2015.05.022